Eric J. Burks

Dr. Eric J. Burks

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Cell
Verified
Journal Article
Closed access
AAAdam Abeshouse
Adam Abeshouse
JAJaeil Ahn
Jaeil Ahn
RARehan Akbani
Rehan Akbani
AAAdrian Ally
Adrian Ally
SASamirkumar Amin
Samirkumar Amin
EZErik Zmuda
Erik Zmuda

1 October 2017 in Cell
Verified
Journal Article
Closed access
ARA. Gordon Robertson
A. Gordon Robertson
JKJaegil Kim
Jaegil Kim
HAHikmat Al-Ahmadie
Hikmat Al-Ahmadie
JBJoaquim Bellmunt
Joaquim Bellmunt
GGGuangwu Guo
Guangwu Guo
EZEllen C. Zwarthoff
Ellen C. Zwarthoff

1 August 2017 in Cancer Cell
Verified
Journal Article
Open access
BRBenjamin J. Raphael
Benjamin J. Raphael
RHRalph Hruban
Ralph Hruban
AAAndrew J. Aguirre
Andrew J. Aguirre
RMRichard Moffitt
Richard Moffitt
JYJen Jen Yeh
Jen Jen Yeh
JZJean C. Zenklusen
Jean C. Zenklusen
We performed integrated genomic, transcriptomic, and proteomic profiling of 150 pancreatic ductal adenocarcinoma (PDAC) specimens, including samples with characteristic low neoplastic cellularity. Deep whole-exome sequencing revealed recurrent somatic mutations in KRAS, TP53, CDKN2A, SMAD4, RNF43, ARID1A, TGFβR2, GNAS, RREB1, and PBRM1. KRAS wild-type tumors harbored alterations in other oncogenic drivers, including GNAS, BRAF, CTNNB1, and additional RAS pathway genes. A subset of tumors harbored multiple KRAS mutations, with some showing evidence of biallelic mutations. Protein profiling identified a favorable prognosis subset with low epithelial-mesenchymal transition and high MTOR pathway scores. Associations of non-coding RNAs with tumor-specific mRNA subtypes were also identified. Our integrated multi-platform analysis reveals a complex molecular landscape of PDAC and provides a roadmap for precision medicine.

27 October 2022 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Open access
YZYi Zheng
Yi Zheng
RGRushin H. Gindra
Rushin H. Gindra
EGEmily J. Green
Emily J. Green
EBEric J. Burks
Eric J. Burks
MBMargrit Betke
Margrit Betke
VKVijaya B Kolachalama
Vijaya B Kolachalama
Deep learning is a powerful tool for whole slide image (WSI) analysis. Typically, when performing supervised deep learning, a WSI is divided into small patches, trained and the outcomes are aggregated to estimate disease grade. However, patch-based methods introduce label noise during training by assuming that each patch is independent with the same label as the WSI and neglect overall WSI-level information that is significant in disease grading. Here we present a Graph-Transformer (GT) that fuses a graph-based representation of an WSI and a vision transformer for processing pathology images, called GTP, to predict disease grade. We selected 4,818 WSIs from the Clinical Proteomic Tumor Analysis Consortium (CPTAC), the National Lung Screening Trial (NLST), and The Cancer Genome Atlas (TCGA), and used GTP to distinguish adenocarcinoma (LUAD) and squamous cell carcinoma (LSCC) from adjacent non-cancerous tissue (normal). First, using NLST data, we developed a contrastive learning framework to generate a feature extractor. This allowed us to compute feature vectors of individual WSI patches, which were used to represent the nodes of the graph followed by construction of the GTP framework. Our model trained on the CPTAC data achieved consistently high performance on three-label classification (normal versus LUAD versus LSCC: mean accuracy = 91.2 ± 2.5%) based on five-fold cross-validation, and mean accuracy = 82.3 ± 1.0% on external test data (TCGA). We also introduced a graph-based saliency mapping technique, called GraphCAM, that can identify regions that are highly associated with the class label. Our findings demonstrate GTP as an interpretable and effective deep learning framework for WSI-level classification.

1 December 2020 in Molecular Cell
Verified
Journal Article
Closed access
RHRyan M. Hekman
Ryan M. Hekman
Adam HumeAdam Hume
Adam Hume
RGRaghuveera Kumar Goel
Raghuveera Kumar Goel
KAKristine M. Abo
Kristine M. Abo
JHJessie Huang
Jessie Huang
AEAndrew Emili
Andrew Emili

1 September 2006 in Blood Reviews
Verified
Journal Article
Closed access
EBEric J. Burks
Eric J. Burks
TLThomas P. Loughran
Thomas P. Loughran